FK199B + Zolpidem
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders
Trial Timeline
Mar 1, 2006 → Jul 1, 2007
NCT ID
NCT00999219About FK199B + Zolpidem
FK199B + Zolpidem is a phase 3 stage product being developed by Astellas Pharma for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00999219. Target conditions include Sleep Initiation and Maintenance Disorders.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00999219 | Phase 3 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders